PHI with Cardiosclerosis
How does this condition affect your private health insurance?
Cardiosklerose, often termed cardiac sclerosis or ischemic cardiomyopathy, is a chronic condition characterized by the hardening, scarring, and fibrosis of myocardial tissue. This pathological process primarily results from prolonged and severe myocardial ischemia, usually due to advanced coronary artery disease (atherosclerosis), leading to insufficient blood supply to the heart muscle. The damaged tissue loses its contractile ability, impairing overall cardiac function. It contributes to ventricular remodeling, reduced ejection fraction, and can manifest as heart failure, angina, arrhythmias, or sudden cardiac death. Management aims to prevent further damage and manage symptoms.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Insidious onset, symptoms may develop over weeks to months or be acute in cases like myocardial infarction leading to significant scarring.
Duration of Illness (Lifetime)
Chronic and progressive; a lifelong condition requiring ongoing management.
Cost of Treatment (Initial)
High (e.g., several thousands to tens of thousands of USD for initial diagnosis, hospitalization, and potential revascularization procedures).
Cost of Treatment (Lifetime)
Very high (e.g., hundreds of thousands of USD over decades due to chronic medication, regular follow-ups, and potential hospitalizations for exacerbations or complications).
Mortality Rate
Moderate to high (e.g., 30-50% within 5 years for severe cases, depending on heart failure stage and comorbidities).
Risk of Secondary Damages
Very high (e.g., >80% probability of developing heart failure, arrhythmias, or increased risk of myocardial infarction/stroke).
Probability of Full Recovery
Extremely low (e.g., <5% chance; scarring is irreversible, management focuses on stabilization and slowing progression).
Underlying Disease Risk
Very high (e.g., >90% probability of co-existing coronary artery disease, hypertension, diabetes, hyperlipidemia).